ME Therapeutics Holdings Inc. (CSE:METX)
Canada · Delayed Price · Currency is CAD 2.000
0.00 (0.00%)
At close: May 19, 2026
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 60.1 million as of May 21, 2026. Its market cap has decreased by -42.21% in one year.
Market Cap
60.10M
Enterprise Value
59.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 60.10M, an increase of 316.45%. That is a compound annual growth rate of 73.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 60.10M | -50.00% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satellos Bioscience | 207.27M |
| Helix BioPharma | 120.68M |
| Telescope Innovations | 64.64M |
| Sharp Therapeutics | 63.16M |
| NurExone Biologic | 60.75M |
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |